Time for a conversation about healthcare and drug costs
Canada’s health ministers are currently undergoing a vigorous policy debate on how best to sustain our health-care system. Much of the conversation is centered on the potential development of pharmacare programs and bulk buying strategies to provide affordable access to medicines relied upon by Canadians from coast to coast.
An aging population, weakened economic productivity growth and the growing prevalence of chronic disease are putting additional pressures on health-care budgets and adding urgency to their discussion.
Health care and drug coverage is often used as a political football, and coverage of medicines can make an easy and convenient target as a place to find short-term cost savings despite the need for a broader discussion on overall system reform.
It is time for an adult conversation stripped of rhetoric if we are to find solutions that will provide all Canadians with fair, equitable and affordable access to the medicines they need, when they need them.
Read full blog post via Huffpost Living Canada
Glenn Monteith is Vice President, Innovation and Health Sustainability at Innovative Medicines Canada.